WeedLife News Network

We know what you’re thinking: isn’t an article about “cannabis scalability” a bit premature? After all, we’re talking about an industry that’s still federally illegal. How could businesses plan for the future when marijuana laws are in constant flux? 

True, scalability is trickier in the cannabis sector, but that doesn’t mean business owners shouldn’t consider it. Cannabis may be a new industry, but it’s moving at a rapid pace. Competition in recreationally legal states is already intense, and you’d better believe established companies have a game plan for new markets. 

TORONTO, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the launch of high potency CBD 50 oils, further strengthening the Company’s growing line of cannabis products for wellness oriented consumers. It will be sold to adult-use consumers as SymblTM High CBD 50, and to medical patients as EmblemTM CBD 50.

“The commercialization of our business is fully underway with Aleafia Health’s third major product release in the last month,” said Aleafia Health CEO Geoff Benic. “CBD 50 formulas are differentiated and highly sought after formats in both the medical and adult-use markets which further reinforces our cannabis extract market leadership position.”

CBD sales to medical patients commenced today, with product shipments to the adult-use market expected later this month. Highlights include:

For Investor & Media Relations:

Nicholas Bergamini, VP Investor Relations
1-833-879-2533
IR@AleafiaHealth.com
LEARN MORE: www.AleafiaHealth.com

As a matter of federal law, yes, cannabis will be descheduled entirely if the MORE Act becomes law. And not only that, but all federal marijuana convictions will be expunged

We have spilled a good bit of ink on this blog writing about the MORE Act (Marijuana Opportunity and Expungement Act) which is finally headed to a floor vote in the House, probably tomorrow, December 3. The MORE Act ends federal marijuana prohibition and the criminalization of cannabis by descheduling marijuana from the Controlled Substances Act (CSA).

That would be great, of course. Assuming the House version (HR 3884) passes, it will be crucial for the Senate version (S 2227), sponsored by Vice-President-Elect Kamala Harris, to also see daylight in the upper chamber. My guess is it won’t, unless both Democratic candidates prevail in the Georgia runoffs this January, resulting in Mitch McConnell’s replacement as Senate Majority Leader.

But that’s a question for another day. For now, I want to highlight what would happen if the MORE Act does become law someday soon, because I’m seeing some bad information out there. The biggest point of confusion seems to be the idea that if the MORE Act passes, cannabis will become legal nationwide. It won’t. As a matter of federal law, yes, cannabis will be descheduled entirely. And not only that, but all federal marijuana convictions will be expunged — even the folks who were captured with many tons of cannabis in helicopters and submarines. But state laws will not be preempted in the least.

Does this mean someone could still be arrested for walking around with an ounce of cannabis in e.g. Boise, Idaho, the day after the MORE Act becomes federal law? Yes it does! And that’s a shame, because most cannabis arrests today are for simple possession, and most are made under state laws and by state police.

More Americans than ever support the idea of making cannabis legal for both medical and recreational use. They have proven that again and again at the ballot box, and they’ve shown up in bigger numbers than ever for the latest Gallup Poll.

Gallup releases its survey of Americans’ opinions on a range of issues every year, including the legalization of weed. The most recent survey found that 68 percent of those questioned favored legalization. That’s the highest number in five decades.

The survey also captures the public zeitgeist, as it was released in the same month that voters in Arizona, New Jersey, Montana, and South Dakota all voted to legalize recreational use of marijuana. Those in Mississippi did the same for medical marijuana.

All but three groups support legalization.

The new survey found some interesting data on what groups support marijuana the most and the least. That included an extremely small gender divide. Of those surveyed by Gallup, 69 percent of men and 66 percent of women favored legalization.

Age groups showed a larger divide, although every age group had a majority that supported legalization. When separated by age groups, the percentage in favor of making cannabis legal broke out as follows.

The U.S. Department of Agriculture (USDA) Risk Management Agency (RMA) has announced an expansion of the pilot Multi-Peril Crop Insurance (MPCI) plan for hemp that will take effect in the 2021 crop year.

MCPI is the most common form of the federal crop insurance programme in the USA that insures against crop yield losses from all natural perils such as weather, fire and pestilence by enabling farmers to insure a certain percentage of historical crop production.

While delivered by private companies, MPCI is reinsured by the federal government.

The new states to be included for MPCI coverage are Arizona, Arkansas, Nevada and Texas – but only select counties within each. Additionally, 13 new counties are being included in states with existing coverage.

Just when we thought election season was over, supporters of marijuana legalization are gearing up for one last major fight of the season. That is because the last hope for full cannabis legalization at the federal level fully depends on the outcome of two special elections for U.S. Senate in Georgia on January 3, 2021. 

Simply put, if the Democratic candidates win both of these seats, flipping control of the U.S. Senate to the Democrats, legalization supporters will have their best opportunity to end the decades long disastrous policy of cannabis prohibition. A Republican victory in either one of these elections means there is little to no chance of federal legalization until at least 2023, and likely much longer. After all, the party in control of the White House typically loses seats in Congress in midterm elections, making the prospects of unified Democratic government after the 2022 elections narrow at best. 

Democratic U.S. Senate candidate Jon Ossoff of Georgia speaks to supporters during a rally on ... [+]

 GETTY IMAGES

It is worth saying that it shouldn’t have to be this way. Marijuana legalization is not a heavily partisan issue. It enjoys widespread support nationwide, with the most recent Gallup poll finding 68% of Americans support legalizing marijuana for adults, including 48% of Republicans and 49% of self-identified conservatives. In this past election, legalization was passed by voters in every state where it was on the ballot, all by convincing margins. This included win tallies of 54% in deep red South Dakota, 57% in conservative Montana, and a whopping 60% in now purple Arizona. 

This week the U.S. House of Representatives is expected to vote on a bill that would remove marijuana from the Controlled Substances Act and require federal courts to expunge many prior marijuana offenses. It will be the first time the full House will vote on ending the federal prohibition of cannabis.

Morgan Fox with the National Cannabis Industry Association says House passage would “send a really strong message to not only the rest of Congress, but to a lot of other states that the time to end prohibition has come.”

The Marijuana Opportunity Reinvestment and Expungement Act (MORE Act), introduced by Rep. Jerry Nadler (D., N.Y.), would eliminate conflict between state and federal law and allow states to set their own marijuana policies.

“We don't need to have one size fits all. We just need to get rid of prohibition and then let the states do what the states are doing. It's essentially what the states have done already. They haven’t waited for the federal government, which is why we have a lot of these discrepancies and challenges,” said Rep. Earl Blumenauer (D., Ore.), who has long pushed for marijuana legalization.

Jars of marijuana are seen on display at Montana Advanced Caregivers, a medical marijuana dispensary, Nov. 11, 2020, in Billings, Mont. Recreational marijuana initiatives passed in four states this year, from liberal New Jersey to conservative Montana and South Dakota. Advocates' next goal is to get marijuana removed from a federal list of illegal drugs with no accepted medical use and high potential for abuse. (AP Photo/Matthew Brown)

Cannabis delivery is finally becoming available across the country, but despite this being many a-weed smokers’ dream, the service is still new and a little difficult to navigate. Some delivery services seem a little iffy, or not entirely trustworthy, while others seem to only cater to customers that are willing to shell out exorbitant amounts of money for the privilege of having weed delivered directly to their door.

Every service is a little bit different, so choosing the right one can take a little time and trial and error. To help you find the right weed delivery service for your needs, we’ve created this simple guide featuring tips for selecting a reputable delivery service to make your weed delivery dreams a reality.

Is This Delivery Service Compliant?

A legitimate cannabis delivery service must comply with state and local cannabis rules and regulations. As a consumer, you want your weed delivery to be above board not only to prevent yourself from getting into legal trouble but also to ensure that the products you buy are from a reputable source. If you can’t trust them to follow basic regulations, how can you trust them to bring you top-notch cannabis?

Best practice to ensure you are ordering from a compliant delivery service is to look for the company’s cannabis license, which should be prominently displayed on their website and any email communications.

Is Tax Applied To Your Purchase?

Like other consumer products, recreational and medical marijuana purchases are taxed. If the cannabis delivery service you choose does not apply tax to their products (either before or after purchase) they are likely not compliant with local regulations and restrictions.

On Tuesday, Dec. 8, from 1-2 p.m. CST, the Minority Cannabis Business Association (MCBA), along with the U.S. Hemp Roundtable (USHR), will host a free webinar, “Cultivating Entrepreneurship in the Hemp Industry: A Complimentary Webinar for Small and Minority-Owned Companies.” The webinar is designed to provide essential information for small and small minority-owned businesses and engage all industry stakeholders.

Cannabis is a wildly resilient and adaptable plant. It’s been grown and harvested for more than 4,000 years, migrating along ancient trade routes from southeast Asia through Africa and the Middle East, crossing oceans to reach the Americas and points in between. Today, we are just beginning to apply scientific methods to better understand the nature of the cannabis plant itself. The complex interplay of environment, farming techniques, and genetics allow us to coax and nurture various attributes out of each variety gently. 

But moving forward starts with looking back and understanding what grows well, where it grows well, and why. Doing so represents not just the future of cannabis farming but also the future and viability of our planet to sustain us.

The homegrown science of cannabis

Agricultural scientists are hamstrung by cannabis’ storied history. The plant was underappreciated by European power-brokers who considered it a poor man's tobacco only used by marginalized racial groups. This racist perspective led to the criminalization of cannabis in the United States and around the world.  As a result, generations of cannabis farmers, operating outside the norms of agricultural science, organically established the foundations of cannabis science, developing cultivation techniques and naturally selecting and enhancing certain plant traits and qualities. 

Left to their own devices, these early pioneers also created legacies that we are now working hard to unravel. For example, there is no standardized naming taxonomy for cannabis beyond the basic genus and species classifications: cannabis indica, cannabis sativa, cannabis ruderalis. The reality is there are few true cannabis species in modern cultivation. Most of the cultivated cannabis strains are complex poly-hybrids developed by farmers selecting for specific properties, mostly optimizing their strains' THC properties.

For the past 50 years, growers have tinkered with the cannabis plant, creating more powerful and potent flowers. In the 1970s, one could expect THC content of 4 to 6 percent of the dry flower's total weight. By the 1980s and 90s, THC content had almost tripled to 15 percent. Today’s specialized strains now boast a THC content of nearly 25 percent. 

Consuming cannabis before getting behind the wheel is never a good idea, but just how much influence does it have on our driving?

A study published on Tuesday suggests that low doses of CBD don’t have an influence on people’s capabilities to drive. It also found that while THC is capable of impairing drivers, the effects wear off within a period of four hours.

The study, published in the Journal of the American Medical Association, is the first to analyze the impact CBD has on driving, while also providing more information as to how THC affects us behind the wheel.

“These findings indicate for the first time that CBD, when given without THC, does not affect a subject’s ability to drive. That’s great news for those using or considering treatment using CBD-based products,” said the study’s lead author Dr. Thomas Arkell.

Photo by William Krause via Unsplash

The Department of Agriculture Monday announced the expansion of the pilot Multi-Peril Crop Insurance plan for hemp. The expansion and other improvements to the plan, will begin in the 2021 crop year.

USDA Risk Management Agency Administrator Martin Barbre says, “Hemp offers exciting economic opportunities for our nation’s farmers, and we are listening and responding to their risk management needs.”

The program expansion allows for additional states and specific counties to be included in the program. The changes also allow broker contracts for hemp grain and adjust program reporting and billing dates. Sales closing, cancellation, production reporting and termination dates were adjusted to match dates of similar crops.

Meanwhile, USDA adjusted Acreage Reporting Dates based on regional final planting dates. The premium billing dates for all states changed to August 15.

For more information on USDA risk management programs for hemp producers, they are encouraged to visit farmers.gov/hemp.

The recent trend of using CBD in health-related products has been fueled by increasing interest and curiosity about its medicinal value as a natural alternative to synthetic ingredients and chemicals. As a result, the retail market has become inundated with a wide range of topical products containing cannabidiol, all claiming to benefit skin health and facilitate pain management. 

This progressively expanding commercial industry is mainly unregulated and there are no universally recognized or enforced guidelines on what constitutes legitimate, high-quality products. The incentive to capitalize on this emerging market has heightened competition. As demand for CBD-based products climbs, the number of manufacturers, distributors, and retailers has subsequently multiplied to supply it. 

Consumer’s Dilemma

For consumers, this abundance of supply and the unknown methods and standards of quality control can understandably cause considerable uncertainty regarding the legitimacy of retailers and their products. A basic keyword search such as CBD cream near me can bring up relevant results on local markets that specialize in natural health and organic goods, or pharmacies that sell CBD products. You may also come across websites with resourceful information that can guide you in your search. But be cautious of overly promotional content from possibly dubious sources. You’ll likely encounter a lot of buzzwords such as ‘organic’ and ‘bioavailability’ that can be helpful to get familiarized with.

It’s helpful to know how to differentiate between products that qualify as high-standard and safe to use and those that are substandard or inferior. Also, there are ways to recognize a trustworthy source as opposed to a potential scam.

In the 18 months since Arkansas’ first medical marijuana dispensary opened in May 2019, overall sales have surpassed 28,000 pounds. In total, Arkansans have spent $187 million to obtain 28,674 pounds of medical marijuana.

At this rate, officials with the Arkansas Medical Marijuana Commission anticipate sales will reach 30,000 pounds by late December.

Locally, since Plant Family Therapeutics of Mountain Home opened in February, the company has sold 1,303 pounds of medical marijuana.

In Mountain View, since Fiddler’s Green opened in July 2019, the company has sold 1,581 pounds of medical marijuana.

There are 31 dispensaries in operation, with six remaining that are working toward opening. The six include new dispensaries in Hardy, Little Rock, Fayetteville and Osceola, as well as two in Pine Bluff.

Researchers of a new study note that CBD plays an important role in risk reduction for users of high THC cannabis.

Disclaimer: The views expressed in this article solely belong to the author and do not necessarily represent those of The Fresh Toast. 

A U.K. think tank has published as study called Changes in delta‐9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta‐analysis.

A meta-analysis is a fancy word for studying studies, and generally speaking, the larger the sample, the more reliable the results will be, and the Addiction and Mental Health Group at the University of Bath “analysed data from more than 80,000 cannabis street samples tested in the past 50 years in the US, UK, Netherlands, France, Denmark, Italy and New Zealand.”  

However, the very long time span for the sampling may be more of a problem than an asset. Fifty years ago, none of these countries were major producers of hashish.  

Would you smoke cannabis if it meant you might consume less alcohol, tobacco, or prescription drugs? A recent study examining a group of patients adds more convincing evidence to the idea that marijuana is an “exit” drug rather than a gateway drug.

Published in the International Journal of Drug Policy, the study compared survey results of 973 patients who answered questions about how they used alcohol before and after receiving medical cannabis authorizations from their doctors. Among them, 44 percent reported drinking less frequently on a monthly basis, 34 percent consumed fewer standard drinks per week, and eight percent said they drank no alcohol at all in the 30 days prior to completing the survey.

The study’s data is derived from the Canadian Cannabis Patient Survey 2019, a survey of patients registered with licensed producer Tilray, and led by the company’s VP of patient research and access and University of Victoria researcher Philippe Lucas.

Greater Success With Intention

Lucas says the study’s most interesting finding was that when patients had a deliberate intention to use medical cannabis to reduce their alcohol consumption, their odds of drinking less or ceasing drinking altogether were significantly higher.

“About 13 percent of participants cited that they deliberately used medical cannabis to reduce the use of alcohol. Conversely, fewer than one percent worked with their physician to do so,” Lucas says.

While sales of cannabis edibles in general have grown steadily in legal marijuana markets, the cannabis candies segment has seen very strong sales, with cannabis-infused gummies making up 84% of cannabis candy sales so far in 2020 across Arizona, California, Colorado, Nevada and Oregon.

BDSA Consumer Insights data from the beginning of 2020 shows that gummies are the most widely used and most popular ingestible product for recreational (adult-use) cannabis consumers in the United States and Canada. Nearly 60% of America’s cannabis edibles consumers report past 6-month use of gummies.

The benefits of offering a convenient, discrete method of marijuana consumption with an array of flavors to suit any consumers’ taste are key factors leading to the success of marijuana-infused gummy products.

Overall cannabis gummy sales among Arizona, California, Colorado, Nevada and Oregon have seen major growth in recent years, from $20 million in July 2017 to almost $64 million in July 2020. This growth rate far exceeds that of other cannabis edibles.